ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 297 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $230,868 | +13.2% | 5,692 | -3.1% | 0.13% | +10.5% |
| Q2 2022 | $204,000 | -24.4% | 5,872 | 0.0% | 0.11% | -7.3% |
| Q1 2022 | $270,000 | -30.6% | 5,872 | 0.0% | 0.12% | -19.1% |
| Q4 2021 | $389,000 | -10.8% | 5,872 | -15.9% | 0.15% | -15.6% |
| Q3 2021 | $436,000 | -25.1% | 6,984 | -0.6% | 0.18% | -27.4% |
| Q2 2021 | $582,000 | +17.3% | 7,024 | -4.7% | 0.25% | +17.0% |
| Q1 2021 | $496,000 | -11.9% | 7,373 | 0.0% | 0.21% | -20.0% |
| Q4 2020 | $563,000 | +77.6% | 7,373 | 0.0% | 0.26% | +43.2% |
| Q3 2020 | $317,000 | +0.6% | 7,373 | +1.0% | 0.18% | -3.6% |
| Q2 2020 | $315,000 | +50.0% | 7,303 | -2.4% | 0.19% | +11.6% |
| Q1 2020 | $210,000 | – | 7,482 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |